Forward Citations = 366

Loading Chart...

7 inventors (with patents filed for the assignee):

Paul J Buscemi (4 out of 48 patents)

Stanislao F Obino (4 out of 4 patents)

David Benditt (2 out of 7 patents)

4. Keith G Lurie (2 out of 111 patents)

5. Robert Arzbaecher (1 out of 1 patent)

6. Stan Obino (1 out of 1 patent)

7. Brian Jackson (1 out of 1 patent)

5 patents: Sort by Forward Citations

1. 6078834 - Device and method for detection and treatment of syncope (2000-06-20),

2. 5919210 - Device and method for detection and treatment of syncope (1999-07-06),

3. 5800498 - Catheter for implantable rhythm control device (1998-09-01),

4. 5755761 - Atrial pacing catheter and method having multiple electrodes in the (1998-05-26),

5. 5690682 - Device and method for treatment of cardiac arrhythmia (1997-11-25),

Company Overview

Pharmatarget, Inc. is a leading biotechnology company specializing in the development of targeted therapies for various diseases. With a focus on precision medicine, the company's innovative approach aims to revolutionize healthcare by delivering personalized treatment options to patients. Through cutting-edge research and strategic partnerships, Pharmatarget is committed to advancing the future of medicine.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

5 Patents

#310 in Minneapolis, MN

#1,420 in Minnesota

#51,570 in US

Minneapolis, MN, United States of America

Pharmatarget, Inc.

Forward Citations = 366

7 inventors:

Paul J Buscemi (4 out of 48 patents)

Stanislao F Obino (4 out of 4 patents)

David Benditt (2 out of 7 patents)

4. Keith G Lurie (2 out of 111 patents)

5. Robert Arzbaecher (1 out of 1 patent)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Pharmatarget, Inc.. Retrieved from https://idiyas.com/company/pharmatarget

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]